SZSE:300253 (China)
Â
Class A
Â¥
7.96
(+2.71%)
Nov 29
Business Description
Winning Health Technology Group Co Ltd
NAICS : 518210
SIC : 7372
ISIN : CNE1000016F5
Share Class Description:
SZSE:300253: Class ACompare
Compare
Traded in other countries / regions
300253.China IPO Date
2011-08-18Description
Winning Health Technology Group Co Ltd is a China-based company engages in the research, development, manufacture, and sale of software, computers, and its auxiliary equipment; and provision of computer network maintenance and technical services. It also provides regional health information platform, an integrated service platform that integrates hardware network infrastructure, data center, data exchange, and business services.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.7 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | 2.36 | |||||
| Interest Coverage | 9.55 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5.32 | |||||
| Beneish M-Score | -2.27 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.8 | |||||
| 3-Year EBITDA Growth Rate | -3.2 | |||||
| 3-Year EPS without NRI Growth Rate | -4.6 | |||||
| 3-Year Book Growth Rate | 7.7 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 32.87 | |||||
| Future 3-5Y Total Revenue Growth Rate | 16.61 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.27 | |||||
| 9-Day RSI | 53.2 | |||||
| 14-Day RSI | 54.02 | |||||
| 6-1 Month Momentum % | 24.59 | |||||
| 12-1 Month Momentum % | -0.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.22 | |||||
| Quick Ratio | 3.13 | |||||
| Cash Ratio | 0.51 | |||||
| Days Inventory | 25.46 | |||||
| Days Sales Outstanding | 120.62 | |||||
| Days Payable | 133.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.25 | |||||
| Dividend Payout Ratio | 0.09 | |||||
| 3-Year Dividend Growth Rate | -26.3 | |||||
| Forward Dividend Yield % | 0.25 | |||||
| 5-Year Yield-on-Cost % | 0.25 | |||||
| 3-Year Average Share Buyback Ratio | -0.2 | |||||
| Shareholder Yield % | 0.11 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44.32 | |||||
| Operating Margin % | 20.12 | |||||
| Net Margin % | 11.34 | |||||
| FCF Margin % | 1.21 | |||||
| ROE % | 6.33 | |||||
| ROA % | 4.29 | |||||
| ROIC % | 8.99 | |||||
| ROC (Joel Greenblatt) % | 91.46 | |||||
| ROCE % | 6.72 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 48.24 | |||||
| Forward PE Ratio | 28.01 | |||||
| PE Ratio without NRI | 37.02 | |||||
| Shiller PE Ratio | 49.76 | |||||
| Price-to-Owner-Earnings | 106.13 | |||||
| PS Ratio | 5.48 | |||||
| PB Ratio | 2.92 | |||||
| Price-to-Tangible-Book | 4.55 | |||||
| Price-to-Free-Cash-Flow | 568.57 | |||||
| Price-to-Operating-Cash-Flow | 52.37 | |||||
| EV-to-EBIT | 38.46 | |||||
| EV-to-EBITDA | 38.46 | |||||
| EV-to-Revenue | 5.58 | |||||
| EV-to-FCF | 460 | |||||
| Price-to-Projected-FCF | 3.72 | |||||
| Price-to-Median-PS-Value | 0.37 | |||||
| Price-to-Graham-Number | 2.74 | |||||
| Price-to-Net-Current-Asset-Value | 8.21 | |||||
| Earnings Yield (Greenblatt) % | 2.6 | |||||
| FCF Yield % | 0.22 | |||||
| Forward Rate of Return (Yacktman) % | -5.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Winning Health Technology Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 3,175.783 | ||
| EPS (TTM) (Â¥) | 0.165 | ||
| Beta | 1.41 | ||
| Volatility % | 52.34 | ||
| 14-Day RSI | 54.02 | ||
| 14-Day ATR (Â¥) | 0.408971 | ||
| 20-Day SMA (Â¥) | 7.942 | ||
| 12-1 Month Momentum % | -0.78 | ||
| 52-Week Range (Â¥) | 5.11 - 9.08 | ||
| Shares Outstanding (Mil) | 2,186.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Winning Health Technology Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Winning Health Technology Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Winning Health Technology Group Co Ltd Frequently Asked Questions
What is Winning Health Technology Group Co Ltd(SZSE:300253)'s stock price today?
The current price of SZSE:300253 is ¥7.96. The 52 week high of SZSE:300253 is ¥9.08 and 52 week low is ¥5.11.
When is next earnings date of Winning Health Technology Group Co Ltd(SZSE:300253)?
The next earnings date of Winning Health Technology Group Co Ltd(SZSE:300253) is .
Does Winning Health Technology Group Co Ltd(SZSE:300253) pay dividends? If so, how much?
The Dividend Yield %  of Winning Health Technology Group Co Ltd(SZSE:300253) is 0.25% (As of Today), Highest Dividend Payout Ratio of Winning Health Technology Group Co Ltd(SZSE:300253) was 0.36. The lowest was 0.07. And the median was 0.2. The  Forward Dividend Yield % of Winning Health Technology Group Co Ltd(SZSE:300253) is 0.25%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers